T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
about
CAR models: next-generation CAR modifications for enhanced T-cell functionNew Strategies for the Treatment of Solid Tumors with CAR-T CellsChimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and ProspectsChimeric Antigen Receptors Modified T-Cells for Cancer TherapyMesothelin-Targeted CARs: Driving T Cells to Solid TumorsThe Evolution of T-cell Therapies for Solid MalignanciesGenetically modified T cells for the treatment of malignant diseaseTowards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionHigh-content molecular profiling of T-cell therapy in oncologyTechnical Considerations for the Generation of Adoptively Transferred T Cells in Cancer ImmunotherapyToxicity and management in CAR T-cell therapyT cell engineering as therapy for cancer and HIV: our synthetic futureSmart CARs engineered for cancer immunotherapyDesigning chimeric antigen receptors to effectively and safely target tumorsIn Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid LeukemiaRegression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma.Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies.Immunotherapy: opportunities, risks and future perspectivesBack to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation.A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer.Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cellsRational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastomaSeatbelts in CAR therapy: How Safe Are CARS?Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.Fully human CD19-specific chimeric antigen receptors for T-cell therapy.A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastomaRigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptorImproving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cellsProgress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.Making Better Chimeric Antigen Receptors for Adoptive T-cell TherapyHigh-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity.Chimeric antigen receptor-modified T cells strike back.Toxicities of chimeric antigen receptor T cells: recognition and management.Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialAdoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Design and development of therapies using chimeric antigen receptor-expressing T cells
P2860
Q26745600-41040D82-488B-499B-8F10-12DCB1BAD85BQ26748500-DC41F9BF-6018-41F5-A535-573A1D8322DEQ26753082-5AB10074-613F-483C-B8D5-0A6F7D34F4C7Q26773309-90CBD6F8-0A22-427C-BBB7-761BC480F86FQ26778759-660D5B9D-D555-4063-AB26-63A4ADD8629DQ26799372-54022B37-18A2-42BB-95AA-4E64C41B5EFEQ26860657-288EA92C-3EF7-422A-8EEB-3798242890B3Q27005830-A81B61D9-29DF-4BD0-8684-F85C4019F9DAQ28066792-65D4247F-1494-40D9-8D60-78EBDC43C1EEQ28073563-1446A661-8A6F-4456-94D6-2DBAFD6BD0F2Q28075314-CADE7FBD-9145-4D15-9233-0988EA6443C3Q28082253-17D1D0B0-945D-47C5-B6F4-1B8654FE84BCQ28087236-BFDB3C49-BC5C-407A-A731-BFA7E89CCAB8Q28088526-515185C9-BC3E-4B93-8AC7-091CC059AF79Q28554677-C4295BC8-3709-4EAA-9ED6-F8D5A65428D8Q33561644-CFC5E463-62D6-42A7-9DB9-C84F286D1797Q33776367-D22DEE3B-E6FC-4D15-A8B8-53C79ACFB4A7Q33940443-92FA7B07-C97B-439A-B7B2-126FAFB69C72Q33941012-9AB4219D-9A40-448C-86C3-6E75BA038DE3Q34380489-06AA0797-E559-4811-8490-E7D862ABB056Q34729692-B94F7201-07FD-4E13-9237-1726D5250170Q35216278-4B05CF5C-F62B-43E7-A913-43E3C1674BF4Q35661999-2B3CA4A3-08C3-4637-ACFA-457EC1B13337Q35741739-FA0318BD-E193-4F9F-9A4A-BA6D8816D594Q35818365-AC2AB60A-099F-4CBD-9695-9A9728F61B7EQ35980893-0DCBE470-6FE8-4C01-AA1B-D9150C71DE83Q36281920-679D0B17-E3DC-453A-B7E3-C841A79E3268Q36356392-42F069A3-8F29-49C1-B1D9-F428C7DEE3F6Q36474226-38B7A561-017B-4D2A-A352-6D8E1BC7A02FQ36557169-44661B38-9E2B-494C-8CC3-082ED4AC1FB9Q36777093-B107E153-AE6C-4D80-B1FF-14BCE5B35496Q36781992-469E0BE5-0066-427D-B6B9-710EB1576C7FQ36830759-86CE5E74-2FEB-4F06-A3CC-CEEC1BE50EA3Q36957716-81A7F26A-F27C-439C-870B-1DBD8E06BE9AQ37040370-AED133DC-3162-451C-B3BE-0DA0FE291632Q37058104-60E269D9-26AD-4243-ADAF-D7B57E4AB790Q37135340-C06E8B80-4F04-4470-B356-D6DEB195A654Q37193096-71A5CE62-C018-4AB2-BCE0-AE12D9F86D16Q37257207-E7F178B0-9FCC-4758-B1C3-514BDDC6B124Q37418289-CBC07CD1-5FFE-4D86-8B82-0A30C37E2568
P2860
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
@en
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
@nl
type
label
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
@en
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
@nl
prefLabel
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
@en
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
@nl
P2093
P2860
P1476
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans
@en
P2093
Andrew R Haas
Bruce L Levine
Carl H June
Marcela V Maus
Michael Kalos
Steven M Albelda
Xiaojun Liu
Yangbing Zhao
P2860
P356
10.1158/2326-6066.CIR-13-0006
P577
2013-07-01T00:00:00Z